4th Annual Duke-Industry Statistics Symposium (DISS 2016)
Precision Medicine in Cancer Research
September 14-16, 2016
The annual symposium is organized by the Department of Biostatistics and Bioinformatics, Duke University School of Medicine, and co-sponsored by Amgen, Boehringer-Ingelheim, ICSA, NC-ASA Chapter, Parexel, Quintiles and SAS. It was established 4 years ago to discuss challenging issues and recent advances related to the clinical development of drugs and devices and to promote research and collaboration among statisticians from industry, academia, and regulatory agencies.
The theme of the DISS 2016 is “Precision Medicine in Cancer Research.” The first day is devoted to six short courses. The 2nd day will start with opening remarks and keynote speech. Dr Eric Peterson, the Director of Duke Clinical Research Institute, and the representatives from the co-sponsors will give the opening remarks. Dr Lisa LaVange, the Director of the Office of Biostatistics from FDA/CDER, will present the keynote speech on “Precision Medicine Initiatives at FDA.” The rest of the 2nd day and the 3rd day morning consist of 17 parallel scientific sessions. A poster session will also be held.
We are looking forward to meeting you in the mid of September at Duke University campus.